Skip to main content
. 2016 Oct 13;58(2):247–259. doi: 10.1093/jrr/rrw098

Table 4.

Pathology characteristics in IG-IMRT and 3DCRT groups

Characteristics IG-IMRT
n = 45
3DCRT
n = 99
P
Pathologic tumor depth 0.221
 ypT0 8 (17.8) 17 (17.2)
 ypT1 2 (4.4) 5 (5.1)
 ypT2 17 (37.8) 26 (26.3)
 ypT3 17 (37.8) 44 (44.4)
 pT4 1 (2.2) 7 (7)
Pathologic lymph node metastasis 0.832
 pN0 34 (75.6) 70 (70.7)
 ypN1 8 (17.8) 21 (21.2)
 ypN2 3 (6.6) 8 (8.1)
Pathologic complete response 8 (17.8) 15 (15.1) 0.527
Median number of resected nodesa 12 (0–21) 10 (0–28) 0.795b
Median number of involved nodesa 0 (0–9) 0 (0–13) 0.321b
Tumor regression grade 0.092
 0 1 (2.2) 8 (8.1)
 1 6 (13.3) 24 (24.2)
 2 8 (17.8) 24 (24.2)
 3 22 (48.9) 26 (26.3)
 4 8 (17.8) 17 (17.2)
Treatment responsec 0.071
 Favorable 30 (66.7) 43 (43.5)
 Unfavorable 15 (33.3) 56 (56.5)
Surgical distal margin 0.383
 Negative 42 (93.3) 92 (92.9)
 Positive 3 (6.7) 7 (7.1)
Circumferential resection margin 0.376
 Negative 43 (95.6) 96 (96.9)
 Positive 2 (4.4) 3 (3.1)
Perineural invasion 0.136
 Negative 35 (77.8) 65 (65.6)
 Positive 10 (22.2) 34 (34.4)
Lymphovascular invasion 0.699
 Negative 38 (84.4) 86 (86.8)
 Positive 7 (15.6) 13 (13.2)
Tumor differentiation 0.823
 Well 6 (13.3) 20 (20.2)
 Moderately 36 (80.0) 77 (77.8)
 Poorly 3 (6.7) 2 (2.0)

Data are presented as n (%), unless otherwise indicated.

aMedian (range).

bt-test.

cFavorable treatment responses included TRG 3 or 4; unfavorable treatment responses included TRG 0–2. IG-IMRT = image-guided intensity-modulated radiotherapy, 3DCRT = 3D conformal radiotherapy.